Evidence map›Paper›PMID 34375640›Full record

ArticleThe Journal of biological chemistry2021

Fused in sarcoma regulates DNA replication timing and kinetics.

Weiyan Jia, Sang Hwa Kim, Mark A Scalf, Peter Tonzi, Robert J Millikin, William M Guns, Lu Liu, Adam S Mastrocola, Lloyd M Smith, Tony T Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Weiyan JiaDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Sang Hwa KimDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Mark A ScalfDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Peter TonziDepartment of Biochemistry and Molecular Pharmacology, New York University Langone Health, New York, New York, USA.
Robert J MillikinDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
William M GunsDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Lu LiuDepartment of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Adam S MastrocolaDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Lloyd M SmithDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Tony T HuangDepartment of Biochemistry and Molecular Pharmacology, New York University Langone Health, New York, New York, USA.
Randal S TibbettsDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Electronic address: rstibbetts@wisc.edu.
University of Wisconsin–Madison · USNYU Langone Health · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
Revealing Proteoforms: The Primary Effectors of Biological FunctionR35GM126914 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Lloyd M Smith · 2018 to 2026
$6.2M
Understanding the mechanistic role of genome stability pathways in regulating cell homeostasisR35GM139610 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Tony Tung Huang · 2021 to 2026
$2.6M
Mechanisms of reversible DUB oxidation in genome stability pathways - RevisionR01ES025166 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, TONY TUNG · 2015 to 2020
$2.3M
Defining the molecular basis of oncogene-induced replication stressR01ES031658 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, TONY TUNG · 2021 to 2025
$2.2M
Genome maintenance functions of CREB/ATF transcription factorsR01CA180765 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI TIBBETTS, RANDAL SCOT · 2013 to 2016
$1.1M
Multi-color Benchtop Flow CytometerS10RR025483 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI BUSHMAN, WADE A · 2009 to 2009
$449k
Mechanisms of mitochondrial damage in ataxia-telangiectasiaR21NS090313 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI TIBBETTS, RANDAL SCOT · 2015 to 2016
$412k
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA180765NCRR NIH HHS S10 RR025483NHGRI NIH HHS T32 HG002760NIEHS NIH HHS R01 ES025166NIEHS NIH HHS R01 ES031658NIGMS NIH HHS R35 GM126914NIGMS NIH HHS R35 GM139610NINDS NIH HHS R21 NS090313
6 · The paper itself

Abstract

Fused in sarcoma (FUS) encodes an RNA-binding protein with diverse roles in transcriptional activation and RNA splicing. While oncogenic fusions of FUS and transcription factor DNA-binding domains are associated with soft tissue sarcomas, dominant mutations in FUS can cause amyotrophic lateral sclerosis. FUS has also been implicated in genome maintenance. However, the underlying mechanisms of its actions in genome stability are unknown. Here, we applied gene editing, functional reconstitution, and integrated proteomics and transcriptomics to illuminate roles for FUS in DNA replication and repair. Consistent with a supportive role in DNA double-strand break repair, FUS-deficient cells exhibited subtle alterations in the recruitment and retention of double-strand break-associated factors, including 53BP1 and BRCA1. FUS

Indexed as

DNA Replication TimingBRCA1 ProteinCell ProliferationDNA Breaks, Double-StrandedDNA RepairHumansKineticsRNA-Binding Protein FUSSarcomaTumor Suppressor p53-Binding Protein 1BRCA1 ProteinRNA-Binding Protein FUSTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1amyotrophic lateral sclerosis (ALS)DNA repairDNA replicationfused in sarcoma (FUS)replication timingRNA binding protein

Identifiers

PMID34375640
PMCPMC8403768
OpenAlexW3190278629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.